Impact of agr Dysfunction on Vancomycin Effectiveness Against MRSA
Author Information
Author(s): Brian T. Tsuji, Robert D. MacLean, Linda D. Dresser, Martin J. McGavin, Andrew E. Simor
Primary Institution: University at Buffalo
Hypothesis
Does agr dysfunction affect the pharmacodynamics of vancomycin in MRSA strains?
Conclusion
agr dysfunction reduces the effectiveness of vancomycin against high bacterial counts in MRSA infections.
Supporting Evidence
- 15% of MRSA isolates were agr dysfunctional, with higher rates in healthcare-associated strains.
- Vancomycin was less effective against high bacterial counts in agr dysfunctional strains.
- The study highlights the importance of agr function in determining treatment outcomes for MRSA infections.
Takeaway
Some bacteria that cause infections can be harder to kill with medicine if they have a certain problem. This study looked at how this problem affects a specific medicine called vancomycin.
Methodology
40 clinical MRSA isolates were tested for agr function and vancomycin effectiveness using time kill experiments.
Limitations
The study included a limited number of strains and did not test a USA300 strain.
Participant Demographics
Clinical isolates from Canadian hospitals and communities.
Statistical Information
P-Value
0.0007
Statistical Significance
p = 0.0007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website